RedHill Biopharma notified by Nasdaq for non-compliance with stockholders' equity requirements on Oct 16, 2025.

Unusual Whales
2025.10.22 20:52
The Company was notified by The Nasdaq Stock Market LLC on October 16, 2025, due to failure to meet the minimum stockholders' equity requirements for continued listing under Listing Rule 5550(b)(1). This notification was regarding RedHill's transaction and signifies the Company's non-compliance with the stipulated regulations.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer